AgomAb Therapeutics NV (AGMB) Insider Trading -- Recent Executive & Director Transactions
3 insiders reported 8 Form 4 transactions for AgomAb Therapeutics NV (AGMB) over the past 18 months (most recent 2026-10-09). Recent activity: Epstein David R (Director) Buy 5,000 shares, Epstein David R (Director) Buy 5,000 shares, Kemula Pierre Thadee Victor (Chief Financial Officer) Buy 3,000 shares, Knotnerus Tim Jasper (Chief Executive Officer) Buy 6,000 shares, Epstein David R (Director) Buy 5,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | Epstein David R | Director | Buy | 5,000 | $44,500 |
| 2026-10-07 | Epstein David R | Director | Buy | 5,000 | $42,850 |
| 2026-10-07 | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | 3,000 | $26,010 |
| 2026-10-07 | Knotnerus Tim Jasper | Chief Executive Officer | Buy | 6,000 | $50,880 |
| 2026-10-07 | Epstein David R | Director | Buy | 5,000 | $43,500 |
| 2026-10-07 | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | 5,000 | $42,850 |
| 2026-10-07 | Knotnerus Tim Jasper | Chief Executive Officer | Buy | 5,000 | $43,500 |
| 2026-10-07 | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | 2,000 | $17,080 |
Source: SEC Form 4 filings · as of 2026-10-09